Development of an anti-GM1 antibody-specific glycomimetic for Guillain-Barré syndrome and multifocal motor neuropathy

Abstract Multifocal motor neuropathy (MMN) is a chronic autoimmune neuropathy predominately affecting motor neurons, caused by IgM antibodies that target the ganglioside GM1. These pathogenic autoantibodies trigger complement-mediated nodal disruption and axonal injury at paranodes and neuromuscular junctions. Similar anti-GM1 antibodies also drive acute forms of peripheral neuropathy, such as Guillain-Barré-Syndrome (GBS), in which molecular mimicry following infection induces cross-reactive immune responses. Antibodies generated against microbial GM1-like glycans bind endogenous GM1, leading to severe neurological symptoms which requires intensive care. Current therapies, such as plasmapheresis and intravenous immunoglobulins (IVIG), can be effective, however, they lack selectivity and can cause adverse effects. We hypothesize that selective depletion of autoreactive anti-GM1 antibodies could provide a targeted therapeutic strategy. This antibody removal can be achieved through multivalent presentation of carbohydrate mimetics of pentasaccharide on a biodegradable poly- l -lysine scaffold. Here we report the development of a lead compound that successfully inhibits binding of anti-GM1 antibodies from patients’ sera to GM1 and effectively prevents binding of anti-GM1 antibodies on terminal axonal networks in vitro and ex vivo.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-79018-8
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of an anti-GM1 antibody-specific glycomimetic for Guillain-Barré syndrome and multifocal motor neuropathy

Hugh John Willison, Emilie Seydoux, Beat Ernst, Pascal Hänggi et al.
Scientific Reports
Peripheral Neuropathies and Disorders
article

Development of an anti-GM1 antibody-specific glycomimetic for Guillain-Barré syndrome and multifocal motor neuropathy

Hugh John Willison, Emilie Seydoux, Beat Ernst, Pascal Hänggi, Delphine Demeestere, Rhona McGonigal, José Boucraut, Émilien Delmont, Lijuan Pang, Ruben Herrendorff, Butrint Aliu, Ania Bialic, Sabrine Salhi, Andreas Steck
article en

Abstract

Abstract Multifocal motor neuropathy (MMN) is a chronic autoimmune neuropathy predominately affecting motor neurons, caused by IgM antibodies that target the ganglioside GM1. These pathogenic autoantibodies trigger complement-mediated nodal disruption and axonal injury at paranodes and neuromuscular junctions. Similar anti-GM1 antibodies also drive acute forms of peripheral neuropathy, such as Guillain-Barré-Syndrome (GBS), in which molecular mimicry following infection induces cross-reactive immune responses. Antibodies generated against microbial GM1-like glycans bind endogenous GM1, leading to severe neurological symptoms which requires intensive care. Current therapies, such as plasmapheresis and intravenous immunoglobulins (IVIG), can be effective, however, they lack selectivity and can cause adverse effects. We hypothesize that selective depletion of autoreactive anti-GM1 antibodies could provide a targeted therapeutic strategy. This antibody removal can be achieved through multivalent presentation of carbohydrate mimetics of pentasaccharide on a biodegradable poly- l -lysine scaffold. Here we report the development of a lead compound that successfully inhibits binding of anti-GM1 antibodies from patients’ sera to GM1 and effectively prevents binding of anti-GM1 antibodies on terminal axonal networks in vitro and ex vivo.

Scientific Reports
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon